Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 110.67
   
  • Change Today:
    $3.05
  • 52 Week High: $117.41
  • 52 Week Low: $66.59
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 19,545,205
  • Market Cap: $137,895m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 110.67
Change Today $ 3.05
% Change 2.83 %
52 Week High $117.41
52 Week Low $66.59
Volume 19,545,205
Shares Issued 1,246.00m
Market Cap $137,895m
RiskGrade 120

What The Brokers Say

Strong Buy 10
Buy 9
Neutral 8
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 27-Jun-2025

Time Volume / Share Price
15:59 6,200 @ $110.66
15:59 9,500 @ $110.66
15:59 100 @ $110.64
15:59 100 @ $110.62
15:59 400 @ $110.62

Top of Page